Biopharma News

Dec 12, 2013
By BioPharm International Editors
Johnson&Johnson will open a network of partnering offices across the UK.
Nov 27, 2013
By BioPharm International Editors
Additional companies join Merck KGaA and Neviah Genomics in the Israel BioIncubator.
Nov 27, 2013
By BioPharm International Editors
The Indiana Biosciences Research Institute will accelerate collaboration and focus on human-health solutions.
Nov 25, 2013
By BioPharm International Editors
Merck KGaA plans to build a new biomanufacturing facility in Nantong, China.
Nov 11, 2013
By BioPharm International Editors
Shire's agreement to acquire ViroPharma will strengthen its rare-disease portfolio.
Nov 06, 2013
By BioPharm International Editors
ISPE names Novartis' US Flu Cell Culture facility as award winner.
Nov 01, 2013
By BioPharm International Editors
KaloBios Pharmaceuticals receives FDA Orphan Drug Designation for KB001-A in treatment of cystic fibrosis patients.
Oct 29, 2013
By BioPharm International Editors
GSK and the Gates Foundation will invest a combined $1.8 million in early stage research into vaccine thermostability.
Oct 28, 2013
By BioPharm International Editors
Zhoydro ER is the first drug to have updated labeling now required for all ER/LA opioid analgesics.
Oct 23, 2013
By BioPharm International Editors
Amarin cuts staff in half after an FDA committee rejects its product label expansion.
native1_300x100
lorem ipsum